Cargando…
Bacteremia in hemodialysis patients
Infection is a common complication and is the second leading cause of death in hemodialysis patients. The risk of bacteremia in hemodialysis patients is 26-fold higher than in the general population, and 1/2-3/4 of the causative organisms of bacteremia in hemodialysis patients are Gram-positive bact...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099594/ https://www.ncbi.nlm.nih.gov/pubmed/27872830 http://dx.doi.org/10.5527/wjn.v5.i6.489 |
_version_ | 1782465992485502976 |
---|---|
author | Suzuki, Masashi Satoh, Nobuhiko Nakamura, Motonobu Horita, Shoko Seki, George Moriya, Kyoji |
author_facet | Suzuki, Masashi Satoh, Nobuhiko Nakamura, Motonobu Horita, Shoko Seki, George Moriya, Kyoji |
author_sort | Suzuki, Masashi |
collection | PubMed |
description | Infection is a common complication and is the second leading cause of death in hemodialysis patients. The risk of bacteremia in hemodialysis patients is 26-fold higher than in the general population, and 1/2-3/4 of the causative organisms of bacteremia in hemodialysis patients are Gram-positive bacteria. The ratio of resistant bacteria in hemodialysis patients compared to the general population is unclear. Several reports have indicated that hemodialysis patients have a higher risk of methicillin-resistant Staphylococcus aureus infection. The most common site of infection causing bacteremia is internal prostheses; the use of a hemodialysis catheter is the most important risk factor for bacteremia. Although antibiotic lock of hemodialysis catheters and topical antibiotic ointment can reduce catheter-related blood stream infection (CRBSI), their use should be limited to necessary cases because of the emergence of resistant organisms. Systemic antibiotic administration and catheter removal is recommended for treating CRBSI, although a study indicated the advantages of antibiotic lock and guidewire exchange of catheters over systemic antibiotic therapy. An infection control bundle recommended by the Center for Disease Control and Prevention succeeded in reducing bacteremia in hemodialysis patients with either a catheter or arteriovenous fistula. Appropriate infection control can reduce bacteremia in hemodialysis patients. |
format | Online Article Text |
id | pubmed-5099594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-50995942016-11-21 Bacteremia in hemodialysis patients Suzuki, Masashi Satoh, Nobuhiko Nakamura, Motonobu Horita, Shoko Seki, George Moriya, Kyoji World J Nephrol Minireviews Infection is a common complication and is the second leading cause of death in hemodialysis patients. The risk of bacteremia in hemodialysis patients is 26-fold higher than in the general population, and 1/2-3/4 of the causative organisms of bacteremia in hemodialysis patients are Gram-positive bacteria. The ratio of resistant bacteria in hemodialysis patients compared to the general population is unclear. Several reports have indicated that hemodialysis patients have a higher risk of methicillin-resistant Staphylococcus aureus infection. The most common site of infection causing bacteremia is internal prostheses; the use of a hemodialysis catheter is the most important risk factor for bacteremia. Although antibiotic lock of hemodialysis catheters and topical antibiotic ointment can reduce catheter-related blood stream infection (CRBSI), their use should be limited to necessary cases because of the emergence of resistant organisms. Systemic antibiotic administration and catheter removal is recommended for treating CRBSI, although a study indicated the advantages of antibiotic lock and guidewire exchange of catheters over systemic antibiotic therapy. An infection control bundle recommended by the Center for Disease Control and Prevention succeeded in reducing bacteremia in hemodialysis patients with either a catheter or arteriovenous fistula. Appropriate infection control can reduce bacteremia in hemodialysis patients. Baishideng Publishing Group Inc 2016-11-06 2016-11-06 /pmc/articles/PMC5099594/ /pubmed/27872830 http://dx.doi.org/10.5527/wjn.v5.i6.489 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Minireviews Suzuki, Masashi Satoh, Nobuhiko Nakamura, Motonobu Horita, Shoko Seki, George Moriya, Kyoji Bacteremia in hemodialysis patients |
title | Bacteremia in hemodialysis patients |
title_full | Bacteremia in hemodialysis patients |
title_fullStr | Bacteremia in hemodialysis patients |
title_full_unstemmed | Bacteremia in hemodialysis patients |
title_short | Bacteremia in hemodialysis patients |
title_sort | bacteremia in hemodialysis patients |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099594/ https://www.ncbi.nlm.nih.gov/pubmed/27872830 http://dx.doi.org/10.5527/wjn.v5.i6.489 |
work_keys_str_mv | AT suzukimasashi bacteremiainhemodialysispatients AT satohnobuhiko bacteremiainhemodialysispatients AT nakamuramotonobu bacteremiainhemodialysispatients AT horitashoko bacteremiainhemodialysispatients AT sekigeorge bacteremiainhemodialysispatients AT moriyakyoji bacteremiainhemodialysispatients |